Market revenue in 2022 | USD 237.8 million |
Market revenue in 2030 | USD 436.7 million |
Growth rate | 7.9% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.46% in 2022. Horizon Databook has segmented the Japan dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
The country has a well-established healthcare system and high adoption of advanced diagnosis tests & therapies for effective diagnosis & management of dry eye. Presence of key players in Japan is also a major factor fueling the market growth. Otsuka Pharmaceutical Co., Ltd. and Santen Pharmaceuticals, headquartered in Japan, are among the leading companies offering various products for dry eye syndrome treatment.
For instance, in November 2022, Santen Pharmaceutical Co., Ltd. launched DIQUAS LX, an ophthalmic solution for the treatment of dry eye, in Japan. Furthermore, presence of dry eye treatment therapeutics manufacturers in the region and continuous R&D activities by them for the introduction of innovative dry eye therapies are contributing to market growth in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account